LIGAND PHARMACEUTICALS INCORPORATED Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$44.00K, a 104.16% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $1.06M.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2021-03-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $2.36M.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$1.17M.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was $0.00.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.00K 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | -$44.00K 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $2.36M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $2.95M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $3.35M 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | $1.06M 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | -$1.17M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $377.00K 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2020-09-30 | -$50.00K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | -$160.00K 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | -$169.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $83.00K 10-K · filed 2022-02-28 | |||
| 2019-09-30 | -$88.00K 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $7.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $130.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$215.00K 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |